Original Research
Published on 12 Mar 2025
Abemaciclib in combination with therapies for patients with metastatic breast cancer: a phase 1b study
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2025.1555921
- 846 views
- Frontiers in Oncology
- Breast Cancer
- Articles
Type at least 3 characters
1,317 articles
Original Research
Published on 11 Mar 2025
Impact of wearing external breast prosthesis on body posture of patients after unilateral mastectomy: a randomized controlled trial
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2025.1456562
- 353 views
Original Research
Published on 11 Mar 2025
The value of intratumoral and peritumoral radiomics features based on multiparametric MRI for predicting molecular staging of breast cancer
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2025.1379048
- 458 views
Study Protocol
Published on 11 Mar 2025
Efficacy of thunder-fire moxibustion for cancer-related fatigue in breast cancer survivors: study protocol for a randomized controlled trial
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2025.1496741
- 759 views
Original Research
Accepted on 10 Mar 2025
Abemaciclib Treatment Patterns and Outcome in HR+/HER2-Locally Advanced or Metastatic Breast Cancer: A Real-World Study from Kuwait and Lebanon
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2025.1437380
- 163 views
Original Research
Published on 10 Mar 2025
Clinical outcomes and aesthetic results of reverse sequence endoscopic versus traditional bilateral nipple-sparing mastectomy with immediate implant-based breast reconstruction-an analysis of initial 116 patients from single institution
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2025.1496592
- 345 views
Review
Published on 10 Mar 2025
Real-world effectiveness of CDK4/6i in first-line treatment of HR+/HER2− advanced/metastatic breast cancer: updated systematic review
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2025.1530391
- 1,194 views
Case Report
Accepted on 07 Mar 2025
Case Report: Unlocking Opportunities in HER2-Targeted Antibody-Drug Conjugates for Bulky Leptomeningeal Metastatic Breast Cancer
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2025.1559085
- 117 views
Case Report
Published on 06 Mar 2025
Malignant adenomyoepithelioma of the breast with axillary lymph node metastasis: a case report and review of the literature
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2025.1496057
- 576 views
Original Research
Published on 05 Mar 2025
Predictive factors for outcome in HER2-low breast cancer patients after neoadjuvant chemotherapy
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2025.1459444
- 432 views
Review
Published on 04 Mar 2025
Mechanisms, assessment, and exercise interventions for skeletal muscle dysfunction post-chemotherapy in breast cancer: from inflammation factors to clinical practice
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2025.1551561
- 714 views
Systematic Review
Published on 04 Mar 2025
A meta-analysis and systematic review of different cyclin-dependent kinase 4/6 inhibitors in breast cancer
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2025.1472407
- 693 views
Review
Published on 04 Mar 2025
A case of high-grade adenosquamous carcinoma of the breast: case report and literature review
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2025.1548036
- 507 views
Original Research
Published on 03 Mar 2025
The effect of Time-Acupoints-Space Acupuncture on fatigue in postoperative chemotherapy patients with breast cancer: a randomized controlled trial
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2025.1518278
- 712 views
Methods
Accepted on 28 Feb 2025
Automatic Joint Segmentation and Classification of Breast Ultrasound Images via MTL-OCA
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2025.1567577
Systematic Review
Published on 28 Feb 2025
PD-1/PD-L1 inhibitors plus chemotherapy versus chemotherapy alone for Asian patients with advanced triple-negative breast cancer: a phase III RCTs based meta-analysis
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2025.1540538
- 913 views